Reconstruction of the Orbit With a Bioresorbable Polycaprolactone Implant
1 other identifier
interventional
80
1 country
1
Brief Summary
Patients with orbital injuries are entered into the trial. Age: 20 - 70. After obtaining appropriate consent, they are entered into either a control arm where reconstruction of the orbit is done with a titanium mesh (established practice) or the experimental arm where reconstruction is by a bioresorbable implant made of polycaprolactone. Patients are followuped at 1 week, 1 month, 3 months, 6 months \& 12 months. CT scan of the orbits are performed preop, 6 months \& 12 months. End point is the 12 month follow-up appointment. Visual acuity, range of motion, enophthalmos \& diplopia are assessed in follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jul 2004
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2004
CompletedFirst Submitted
Initial submission to the registry
October 5, 2005
CompletedFirst Posted
Study publicly available on registry
October 6, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2007
CompletedMay 13, 2008
May 1, 2008
October 5, 2005
May 12, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
visual acuity
Enophthalmos
Diplopia
Cosmetic appearance
Interventions
Eligibility Criteria
You may qualify if:
- age: 20 - 70 years facial trauma with orbital fractures
You may not qualify if:
- No other coexistent conditions eg. diabetes, heart disease, etc
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National University Hospital
Singapore, 119074, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thiam-Chye Lim, MBBS, FRCS
National University Hospital, Singapore
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 5, 2005
First Posted
October 6, 2005
Study Start
July 1, 2004
Study Completion
July 1, 2007
Last Updated
May 13, 2008
Record last verified: 2008-05